Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation
Sun Yat-sen University · Fifth Affiliated Hospital of Sun Yat-sen University · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
683
total citations
- FWCI
- 26.69
- Percentile
- 100%
- References
- 43
Citations per year
Authors
13- NCNan Chen
Sun Yat-sen University, Fifth Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University Cancer Center
- WFWenfeng Fang
Sun Yat-sen University, Sun Yat-sen University Cancer Center
- JZJianhua Zhan
Sun Yat-sen University, Sun Yat-sen University Cancer Center
- SHShaodong Hong
Sun Yat-sen University, Sun Yat-sen University Cancer Center
- YTYanna Tang
Sun Yat-sen University, Fifth Affiliated Hospital of Sun Yat-sen University
Topics & keywords
Topics
Keywords
- Cancer research
- PD-L1
- Epidermal growth factor receptor
- Medicine
- Immune system
- EGFR inhibitors
- Flow cytometry
- Downregulation and upregulation
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- SYSun Yat-sen University
- NSNatural Science Foundation of Guangdong Province
- DFDirectorate for Biological Sciences
- WJWu Jieping Medical FoundationAward: 320.6750
- NHNational High-tech Research and Development Program
- SRSpecialized Research Fund for the Doctoral Program of Higher Education of China
- SYSun Yat-sen University Cancer Center